Endo International plc – Ordinary Shares (ENDP) was Initiated by JMP Securities to “Mkt Outperform”. JMP Securities advised their investors in a research report released on Apr 21, 2016.
Many Wall Street Analysts have commented on Endo International plc – Ordinary Shares. Shares were Reiterated by Deutsche Bank on Apr 18, 2016 to “Buy” and Lowered the Price Target to $ 61 from a previous price target of $65 .Shares were Reiterated by Piper Jaffray on Mar 28, 2016 to “Overweight” and Lowered the Price Target to $ 79 from a previous price target of $81 .Shares were Reiterated by Deutsche Bank on Mar 21, 2016 to “Buy” and Lowered the Price Target to $ 65 from a previous price target of $68 .
On the company’s financial health, Endo International plc – Ordinary Shares reported $1.36 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Feb 29, 2016. Analyst had a consensus of $1.27. The company had revenue of $1074.00 million for the quarter, compared to analysts expectations of $1066.72 million. The company’s revenue was up 34.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.16 EPS.
Endo International plc – Ordinary Shares opened for trading at $26.28 and hit $28.59 on the upside on Monday, eventually ending the session at $28.49, with a gain of 8.20% or 2.16 points. The heightened volatility saw the trading volume jump to 76,89,124 shares. Company has a market cap of $6,331 M.
In a different news, on Mar 17, 2016, William Spengler (director) purchased 1,000 shares at $29.20 per share price. According to the SEC, on Mar 14, 2016, Roger H Kimmel (director) purchased 1,125 shares at $41.94 per share price. On Mar 7, 2016, Matthew Joseph Maletta (Exec. V.P.,Chief Legal Officer) purchased 500 shares at $44.48 per share price, according to the Form-4 filing with the securities and exchange commission.